Amr Elsherbeny, Hulya Bayraktutan, Nurcan Gumus, Phoebe McCrorie, Andres Garcia-Sampedro, Shreeya Parmar, Alison A. Ritchie, Marian Meakin, Umut Can Oz, Ruman Rahman, Jennifer C. Ashworth, Anna M. Grabowska, Cara Moloney and Cameron Alexander
{"title":"Pentablock thermoresponsive hydrogels for chemotherapeutic delivery in a pancreatic cancer model†","authors":"Amr Elsherbeny, Hulya Bayraktutan, Nurcan Gumus, Phoebe McCrorie, Andres Garcia-Sampedro, Shreeya Parmar, Alison A. Ritchie, Marian Meakin, Umut Can Oz, Ruman Rahman, Jennifer C. Ashworth, Anna M. Grabowska, Cara Moloney and Cameron Alexander","doi":"10.1039/D4BM01629G","DOIUrl":null,"url":null,"abstract":"<p >The design of biodegradable and thermoresponsive polymeric hydrogels with tuneable properties holds immense promise for localised and sustained drug delivery. In this study, we designed and synthesised a library of novel pentablock copolymers, incorporating poly(<small>D</small>,<small>L</small>-lactide) (PLA) into methoxypoly(ethylene glycol)-poly(ε-caprolactone)-methoxypoly(ethylene glycol) (mPEG-PCL-mPEG, or PECE) hydrogels to enhance the hydrolytic degradation and drug release profiles. A pentablock copolymer, methoxypoly(ethylene glycol)-<em>b</em>-poly(<small>D</small>,<small>L</small> lactide)-<em>b</em>-poly(ε-caprolactone)-<em>b</em>-poly(<small>D</small>,<small>L</small> lactide)-<em>b</em>-methoxypoly(ethylene glycol) (mPEG-PLA-PCL-PLA-mPEG, or PELCLE), was selected based on its thermoresponsive sol–gel transition behaviour at a physiologically relevant temperature (37 °C). Physicochemical characterisation revealed that both PECE and PELCLE hydrogels self-assembled into micellar structures, with PELCLE exhibiting smaller micellar sizes compared to PECE. The incorporation of PLA led to reduced hydrogel stiffness, enhanced degradability, and decreased swelling compared to PECE. <em>In vitro</em> drug release studies demonstrated that both hydrogels exhibited sustained release of various anti-cancer drugs, with PELCLE generally showing slower release kinetics, highlighting its potential for prolonged drug delivery. For potential pancreatic cancer applications, we evaluated the biocompatibility and therapeutic efficacy of PELCLE hydrogels loaded with gemcitabine and oxaliplatin (GEMOX). <em>In vitro</em> and <em>in vivo</em> studies demonstrated safety and some anti-tumour efficacy of GEMOX-loaded PELCLE compared to free drug administration, attributed to enhanced tumour retention and sustained drug release. These findings highlight the potential of the PELCLE hydrogel as a versatile and effective local drug delivery platform for the treatment of pancreatic cancer and other solid tumours, warranting further investigation towards its clinical translation.</p>","PeriodicalId":65,"journal":{"name":"Biomaterials Science","volume":" 7","pages":" 1831-1848"},"PeriodicalIF":5.8000,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.rsc.org/en/content/articlepdf/2025/bm/d4bm01629g?page=search","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials Science","FirstCategoryId":"5","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/bm/d4bm01629g","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
The design of biodegradable and thermoresponsive polymeric hydrogels with tuneable properties holds immense promise for localised and sustained drug delivery. In this study, we designed and synthesised a library of novel pentablock copolymers, incorporating poly(D,L-lactide) (PLA) into methoxypoly(ethylene glycol)-poly(ε-caprolactone)-methoxypoly(ethylene glycol) (mPEG-PCL-mPEG, or PECE) hydrogels to enhance the hydrolytic degradation and drug release profiles. A pentablock copolymer, methoxypoly(ethylene glycol)-b-poly(D,L lactide)-b-poly(ε-caprolactone)-b-poly(D,L lactide)-b-methoxypoly(ethylene glycol) (mPEG-PLA-PCL-PLA-mPEG, or PELCLE), was selected based on its thermoresponsive sol–gel transition behaviour at a physiologically relevant temperature (37 °C). Physicochemical characterisation revealed that both PECE and PELCLE hydrogels self-assembled into micellar structures, with PELCLE exhibiting smaller micellar sizes compared to PECE. The incorporation of PLA led to reduced hydrogel stiffness, enhanced degradability, and decreased swelling compared to PECE. In vitro drug release studies demonstrated that both hydrogels exhibited sustained release of various anti-cancer drugs, with PELCLE generally showing slower release kinetics, highlighting its potential for prolonged drug delivery. For potential pancreatic cancer applications, we evaluated the biocompatibility and therapeutic efficacy of PELCLE hydrogels loaded with gemcitabine and oxaliplatin (GEMOX). In vitro and in vivo studies demonstrated safety and some anti-tumour efficacy of GEMOX-loaded PELCLE compared to free drug administration, attributed to enhanced tumour retention and sustained drug release. These findings highlight the potential of the PELCLE hydrogel as a versatile and effective local drug delivery platform for the treatment of pancreatic cancer and other solid tumours, warranting further investigation towards its clinical translation.
具有可调特性的可生物降解和热响应性聚合物水凝胶的设计为局部和持续的药物输送提供了巨大的希望。在这项研究中,我们设计并合成了一个新的五嵌段共聚物库,将聚(D, l -丙交酯)(PLA)纳入甲氧基聚乙二醇-聚(ε-己内酯)-甲氧基聚乙二醇(mPEG-PCL-mPEG,或PECE)水凝胶中,以提高其水解降解和药物释放特性。根据其在生理相关温度(37℃)下的热响应性溶胶-凝胶转变行为,选择了五嵌段共聚物甲氧基聚乙二醇-b-聚(D,L丙交酯)-b-聚(ε-己内酯)-b-聚(D,L丙交酯)-b-甲氧基聚乙二醇(mPEG-PLA-PCL-PLA-mPEG,或PELCLE)。理化表征表明,PECE和PELCLE水凝胶均可自组装成胶束结构,其中PELCLE的胶束尺寸比PECE小。与PECE相比,PLA的掺入降低了水凝胶的硬度,增强了可降解性,减少了肿胀。体外药物释放研究表明,这两种水凝胶都表现出多种抗癌药物的缓释,而PELCLE通常表现出较慢的释放动力学,突出了其延长给药时间的潜力。对于潜在的胰腺癌应用,我们评估了装载吉西他滨和奥沙利铂(GEMOX)的PELCLE水凝胶的生物相容性和治疗效果。体外和体内研究表明,与游离给药相比,携带gemox的PELCLE具有安全性和一定的抗肿瘤功效,这归因于增强的肿瘤保留和持续的药物释放。这些发现突出了PELCLE水凝胶作为治疗胰腺癌和其他实体肿瘤的多功能和有效的局部药物递送平台的潜力,值得进一步研究其临床转化。
期刊介绍:
Biomaterials Science is an international high impact journal exploring the science of biomaterials and their translation towards clinical use. Its scope encompasses new concepts in biomaterials design, studies into the interaction of biomaterials with the body, and the use of materials to answer fundamental biological questions.